Skip to main content
. 2016 Mar 21;7(18):25549–25557. doi: 10.18632/oncotarget.8224

Table 2. Overview of Cifdofovir dose levels and DLTs observed in treated patients.

Dose (mg) Treated patients (N) Patients evaluable for DLT (N) Occurrence of DLT (N)
1 3 3 0
2.5 3 3 0
5 3 3 0
6.5 6 6 2
Total 15 15 2

DLT: dose-limiting toxicity ; N: number of patients.